Does RISANKIZUMAB-RZAA Cause Insomnia? 395 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 395 reports of Insomnia have been filed in association with RISANKIZUMAB-RZAA. This represents 0.6% of all adverse event reports for RISANKIZUMAB-RZAA.
395
Reports of Insomnia with RISANKIZUMAB-RZAA
0.6%
of all RISANKIZUMAB-RZAA reports
2
Deaths
128
Hospitalizations
How Dangerous Is Insomnia From RISANKIZUMAB-RZAA?
Of the 395 reports, 2 (0.5%) resulted in death, 128 (32.4%) required hospitalization, and 2 (0.5%) were considered life-threatening.
Is Insomnia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 395 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Insomnia?
ADALIMUMAB (6,888)
DULOXETINE (5,270)
ETANERCEPT (4,983)
PREGABALIN (4,882)
METHOTREXATE (4,757)
LEVOTHYROXINE (4,663)
TOCILIZUMAB (4,001)
PREDNISONE (3,804)
LENALIDOMIDE (3,651)
RITUXIMAB (3,637)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Insomnia Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA